Eli Lilly & Co. vs West Pharmaceutical Services, Inc.
LLY vs WST — side-by-side comparison from reported financials. LLY leads 9, WST leads 2 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
| Metric | LLY | WST |
|---|---|---|
| Price | $1 177.20 | $366.00 |
| Market cap | $1.05T | $25.8B |
| Revenue (TTM) | $79.7B | $3.33B |
| Revenue growth | +31.7% | +2.1% |
| Net margin | 33.5% | 17.0% |
| Free cash flow | $18.2B | $437M |
| Net cash (debt) | ($35.2B) | $589M |
| 1-year price return | +37.6% | +38.9% |
| P/E | 41.6 | 47.7 |
| P/E vs own history (cheap-side %) | 88% | 39% |
| Dividend yield | 0.52% | 0.23% |
| Return on equity | 93% | 19% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 50,000 | 10,800 |
Full résumé-style profiles: LLY CV · WST CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.